那他珠单抗与单纯疱疹病毒性脑膜炎。
Natalizumab and HSV meningitis.
机构信息
Division of Infectious Diseases, Massachusetts General Hospital, Gray-Jackson 504, 55 Fruit Street, Boston, MA 02114, USA.
出版信息
J Neurovirol. 2011 Jun;17(3):288-90. doi: 10.1007/s13365-011-0027-4. Epub 2011 Apr 13.
Abstract
Natalizumab (Tysabri, Biogen Idec and Elan Pharmaceuticals) is a monoclonal antibody approved for use in patients with relapsing multiple sclerosis (MS) as well as moderate to severe Crohn's disease. We report the first case of a patient with a history of MS, on monthly natalizumab, who developed HSV-2 meningitis. We discuss the mechanism of action of natalizumab and review what is known about the reactivation of herpes infection in association with this medication. The question of herpes simplex virus (HSV) and varicella zoster virus (VZV) prophylaxis for patients is raised.
摘要
那他珠单抗（泰萨瑞，百健艾迪和艾尔建制药）是一种已被批准用于治疗多发性硬化症（MS）患者的单克隆抗体，也可用于治疗中度至重度克罗恩病。我们报告了首例患有 MS 病史，每月接受那他珠单抗治疗的患者发生单纯疱疹病毒 2 型（HSV-2）脑膜炎的病例。我们讨论了那他珠单抗的作用机制，并回顾了与这种药物相关的疱疹感染再激活的已知情况。这就引出了关于单纯疱疹病毒（HSV）和水痘带状疱疹病毒（VZV）预防的问题。
相似文献
1
Natalizumab and HSV meningitis.那他珠单抗与单纯疱疹病毒性脑膜炎。
J Neurovirol. 2011 Jun;17(3):288-90. doi: 10.1007/s13365-011-0027-4. Epub 2011 Apr 13.
2
Natalizumab: AN 100226, anti-4alpha integrin monoclonal antibody.那他珠单抗：AN 100226，抗4α整合素单克隆抗体。
Drugs R D. 2004;5(2):102-7. doi: 10.2165/00126839-200405020-00007.
3
Natalizumab for induction of remission in Crohn's disease.那他珠单抗用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2007 Jan 24(1):CD006097. doi: 10.1002/14651858.CD006097.pub2.
4
Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients.纳武利尤单抗治疗患者的中枢神经系统单纯疱疹和水痘带状疱疹病毒感染。
Clin Infect Dis. 2013 Sep;57(6):849-52. doi: 10.1093/cid/cit376. Epub 2013 May 31.
5
Natalizumab for induction of remission in Crohn's disease.那他珠单抗用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2006 Jul 19(3):CD006097. doi: 10.1002/14651858.CD006097.
6
Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease.水痘带状疱疹性脑膜炎并发克罗恩病的肿瘤坏死因子和皮质类固醇联合治疗。
World J Gastroenterol. 2013 Jun 7;19(21):3347-51. doi: 10.3748/wjg.v19.i21.3347.
7
Natalizumab for the treatment of Crohn's disease.那他珠单抗用于治疗克罗恩病。
Expert Rev Clin Immunol. 2010 Jul;6(4):513-9. doi: 10.1586/eci.10.38.
8
Natalizumab (Tysabri) treatment for relapsing multiple sclerosis.那他珠单抗（泰萨比）治疗复发型多发性硬化症。
Neurologist. 2007 Jul;13(4):182-7. doi: 10.1097/01.nrl.0000263760.53418.5b.
9
Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab.在接受那他珠单抗治疗的复发性多发性硬化症患者中出现针对那他珠单抗的抗体。
Mult Scler. 2011 Sep;17(9):1074-8. doi: 10.1177/1352458511404271. Epub 2011 Apr 20.
10
Natalizumab: pharmacology, clinical efficacy and safety in the treatment of patients with Crohn's disease.那他珠单抗：治疗克罗恩病患者的药理学、临床疗效及安全性
Expert Rev Gastroenterol Hepatol. 2007 Oct;1(1):29-39. doi: 10.1586/17474124.1.1.29.
引用本文的文献
1
Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint.COVID-19 大流行期间治疗多发性硬化症的药物：批判性观点。
Curr Neuropharmacol. 2022;20(1):107-125. doi: 10.2174/1570159X19666210330094017.
2
Safety of Newer Disease Modifying Therapies in Multiple Sclerosis.新型多发性硬化症疾病修正疗法的安全性
Vaccines (Basel). 2020 Dec 26;9(1):12. doi: 10.3390/vaccines9010012.
3
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.复发型多发性硬化症中疾病修正疗法的顺序：安全性和免疫学考虑。
J Neurol. 2017 Dec;264(12):2351-2374. doi: 10.1007/s00415-017-8594-9. Epub 2017 Sep 6.
4
The use of natalizumab for multiple sclerosis.那他珠单抗在多发性硬化症治疗中的应用。
Neuropsychiatr Dis Treat. 2017 Jun 28;13:1691-1702. doi: 10.2147/NDT.S114636. eCollection 2017.
5
Infectious Complications of Novel Multiple Sclerosis Therapies.新型多发性硬化症治疗的感染性并发症
Curr Infect Dis Rep. 2017 Feb;19(2):7. doi: 10.1007/s11908-017-0562-0.
6
Bacterial meningitis in a patient with multiple sclerosis receiving Tysabri.一名正在接受泰萨比治疗的多发性硬化症患者发生细菌性脑膜炎。
Iran J Neurol. 2016 Jul 6;15(3):175-6.
7
Disease-modifying therapies and infectious risks in multiple sclerosis.多发性硬化症的疾病修正治疗和感染风险。
Nat Rev Neurol. 2016 Apr;12(4):217-33. doi: 10.1038/nrneurol.2016.21. Epub 2016 Mar 4.
8
Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes.用于治疗复发缓解型多发性硬化症的单克隆抗体疗法：作用机制差异与临床疗效
Ther Adv Neurol Disord. 2015 Nov;8(6):274-93. doi: 10.1177/1756285615605429.
9
Infection risk in patients on multiple sclerosis therapeutics.使用多发性硬化症治疗药物患者的感染风险
CNS Drugs. 2015 Mar;29(3):229-44. doi: 10.1007/s40263-015-0226-2.
10
Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab.接受那他珠单抗治疗的多发性硬化患者出现带状疱疹相关性视网膜和中枢神经系统血管炎。
J Neuroinflammation. 2014 Jan 30;11:19. doi: 10.1186/1742-2094-11-19.
本文引用的文献
1
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.阿仑单抗与干扰素β-1a治疗早期多发性硬化症的对比
N Engl J Med. 2008 Oct 23;359(17):1786-801. doi: 10.1056/NEJMoa0802670.
2
Neurological complications of herpes simplex virus type 2 infection.2型单纯疱疹病毒感染的神经系统并发症
Arch Neurol. 2008 May;65(5):596-600. doi: 10.1001/archneur.65.5.596.
3
Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.使用阿仑单抗治疗的淋巴增殖性疾病患者的感染谱、风险以及预防和筛查建议*
Br J Haematol. 2006 Jan;132(1):3-12. doi: 10.1111/j.1365-2141.2005.05789.x.
4
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.那他珠单抗治疗克罗恩病后发生的进行性多灶性白质脑病。
N Engl J Med. 2005 Jul 28;353(4):362-8. doi: 10.1056/NEJMoa051586. Epub 2005 Jun 9.
5
Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.接受那他珠单抗治疗的患者发生进行性多灶性白质脑病。
N Engl J Med. 2005 Jul 28;353(4):375-81. doi: 10.1056/NEJMoa051847. Epub 2005 Jun 9.
6
Alpha4 integrins as therapeutic targets in autoimmune disease.α4整合素作为自身免疫性疾病的治疗靶点。
N Engl J Med. 2003 Jan 2;348(1):68-72. doi: 10.1056/NEJMe020157.
7
Natalizumab for active Crohn's disease.那他珠单抗用于活动性克罗恩病
N Engl J Med. 2003 Jan 2;348(1):24-32. doi: 10.1056/NEJMoa020732.
8
A controlled trial of natalizumab for relapsing multiple sclerosis.那他珠单抗治疗复发型多发性硬化症的对照试验。
N Engl J Med. 2003 Jan 2;348(1):15-23. doi: 10.1056/NEJMoa020696.
Zotero 插件